Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

101 to 125 of 259 results

New regenerative company Cesca created through merger

17-07-2013

USA-based ThermoGenesis (Nasdaq: KOOL), a leading supplier of enabling technologies for the processing…

BiotechnologyCesca TherapeuticsMergers & AcquisitionsThermoGenesisTotipotentRx

Ocera Thera and Tranzyme complete merger

16-07-2013

US clinical-stage biopharma firm Ocera Therapeutics and Tranzyme (Nasdaq: TZYM) have completed their…

BiotechnologyMergers & AcquisitionsNephrology and HepatologyOcera TherapeuticsOCR-002Tranzyme

Italy's Chiesi gains rights to uniQure's Glybera

12-07-2013

Netherlands-based venture capital backed human gene therapy firm uniQure has signed collaboration agreements…

BiotechnologyChiesi FarmaceuticiGlyberaLicensingMergers & AcquisitionsPharmaceuticaluniQure

Serodus to acquire Phlogo to expand cardiovascular portfolio

12-07-2013

Norwegian biopharma company Serodus (Oslo Axess: SER) says that, following approval by an extraordinary…

BiotechnologyCardio-vascularMergers & AcquisitionsPhlogoSER130SER140Serodus

Nile Therapeutics will merge with Capricor to become new company focused on heart disease

08-07-2013

USA-based Nile Therapeutics (OTCQB: NLTX) has today (July 8) announced a merger with privately-held Californian…

BiotechnologyCapricorCapricor TherapeuticscenderitideMergers & AcquisitionsNile Therapeutics

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer

01-07-2013

Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

MorphoSys and Celgene in deal to advance MOR202 for multiple myeloma

27-06-2013

German biotech firm MorphoSys (FSE: MOR) and USA-based Celgene (Nasdaq: CELG), the world's largest independent…

BiotechnologyCelgeneEuropeLicensingMergers & AcquisitionsMOR202MorphoSysOncology

Valneva to sell French CMO operations to India's Biological E

07-06-2013

Biotech firm Valneva (Euronext: VLA), the company recently created through the merger of France's Vivalis…

Biological E LtdBiotechnologyEB66FinancialMergers & AcquisitionsProductionValneva

Life Sciences IPOs have biggest month - May - in 13 years, reports Burrill

07-06-2013

A total of eight life sciences companies went public on US exchanges in May, the busiest month for initial…

BiotechnologyFinancialLicensingMergers & AcquisitionsPharmaceutical

The Medicines Co to acquire ProFibrix but deal hinges on trial results

05-06-2013

US drugmaker The Medicines Company (Nasdaq: MDCO) says it has reached agreement to acquire all of the…

BiotechnologyFibrocapsMergers & AcquisitionsPharmaceuticalProFibrixThe Medicines Company

Biotie buys option to acquire Neurelis, and opportunity for epilepsy candidate

04-06-2013

Finland-based biotech firm Biotie Therapies (Nasdaq-OMX; BTH1V) says that it has obtained an exclusive…

BiotechnologyBiotie TherapiesMergers & AcquisitionsNeurelisNeurologicalNRL-1Pharmaceutical

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos

30-05-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

Ignyta acquires Actagene Oncology and entry into cancer personalized medicine

21-05-2013

Privately-held US biotechnology company, Ignyta, which engages in catalyzing personalized medicine in…

Actagene OncologyBiotechnologyIgnytaMergers & AcquisitionsOncology

Merger between Intercell and Vivalis planned to complete soon

14-05-2013

French biotech firm Vivalis (Euronext: VLS) previously-announced acquisition of Intercell (ICEL.VI) in…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Biotech industry has "implementation gap" around demonstrating the value of products under development

07-05-2013

Ernst & Young's annual biotech report shows strong performance by major players but a challenging environment…

BiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaResearch

Ligand acquires financial rights to over 15 development programs from Selexis

01-05-2013

US drugmaker Ligand Pharmaceuticals (Nasdaq: LGND) has acquired a portfolio of potential future milestone…

BiotechnologyLigand PharmaceuticalsMergers & AcquisitionsResearchSelexis

OPKO Health to acquire PROLOR Biotech in $480 million stock deal

25-04-2013

Continuing on its acquisitive path, US drugmaker OPKO Health (NYSE: OPK) has signed a definitive agreement…

BiotechnologyMergers & AcquisitionsMetabolicsOPKO HealthPharmaceuticalPROLOR Biotech

Abbott Labs told it cannot acquire Russia's Petrovax Farm

22-04-2013

The Russian government has imposed a ban on the sale of Petrovax Farm, one of Russia's leading vaccines…

Abbott LaboratoriesBiotechnologyMergers & AcquisitionsPetrovax FarmVaccines

Life Technologies acquires South Korea's KDR Biotech

15-04-2013

USA-based Life Technologies (Nasdaq: LIFE) has acquired KDR Biotech, a leading reagents distributor based…

Asia-PacificBiotechnologyKDR BiotechLife TechnologiesMergers & Acquisitions

Resverlogix to spin-out RVX Thera to unlock epigenetics platform value

10-04-2013

Canadian drugmaker Resverlogix (TSX:RVX), which is exploring a sale, says that its board of directors…

ApolipoproteinBiotechnologyImmunologicalsMergers & AcquisitionsOncologyResverlogixRVX TherapeuticsRVX-208

OriGene to acquire SDIX' Life Science business assets

09-04-2013

Privately-held OriGene Technologies, a genome wide product company for research and diagnostic applications…

BiotechnologyMergers & AcquisitionsOriGene TechnologiesSDIX

101 to 125 of 259 results

Parexel

Parexel

Back to top